Skip to Content

Fabior FDA Approval History

FDA Approved: Yes (First approved May 11, 2012)
Brand name: Fabior
Generic name: tazarotene
Dosage form: Foam
Company: Stiefel Laboratories, Inc.
Treatment for: Acne

Fabior (tazarotene) Foam is a retinoid indicated for the topical treatment of acne vulgaris.

Development Timeline for Fabior

May 14, 2012Approval Stiefel Receives US FDA Approval of Fabior Foam, 0.1%

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.